mFOLFIRINOX (modified FOLFIRINOX)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for mFOLFIRINOX (modified FOLFIRINOX), covering 2025-09-05 to 2025-09-05. Get the full timeline:
Most recent: Clinical Trial Update: Ivosidenib + mFOLFIRINOX in Patients With Resectable Pancreatic Adenocarcinoma [Phase 1]